Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

Mariana Bleker de Oliveira, BSc, Angela Isabel Eugenio, BSc, Veruska Lia Fook Alves, PhD, Daniela Zanatta, PhD, Mihoko Yamamoto, MD PhD, Bryan Eric Strauss, PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 5658.

https://doi.org/10.1182/blood.V128.22.5658.5658

Published: 2016

Journal Articles

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Mariana Bleker de Oliveira, BSc, Veruska Lia Fook Alves, PhD, Angela Isabel Eugenio, BSc, Rodrigo Carlini Fernando, BSc, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 5663.

https://doi.org/10.1182/blood.V128.22.5663.5663

Published: 2016

Journal Articles

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Mariana Bleker de Oliveira, BSc, Paola Marino Dantonio, BSc, Veruska Lia Fook Alves, PhD, Rodrigo Carlini Fernando, BSc, Daniela Teixeira, MSc, Alexandre Basso, PhD, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 4434.

https://doi.org/10.1182/blood.V128.22.4434.4434

Published: 2016

Journal Articles

Silencing of HSP70 and TRIAP1 Genes in Multiple Myeloma Cell Lines Induces Apoptosis through Apaf-1/Caspase 9 Pathway: New Potential Targets on the Way?

Veruska Lia Fook Alves, MsC, Gisele Wally Braga Colleoni, Daniela Bertolli Zanatta, Bryan E. Strauss

Blood (2014) 124 (21): 5175.

https://doi.org/10.1182/blood.V124.21.5175.5175

Published: 2014

Journal Articles

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Veruska Lia Fook Alves, Walter Moises Tobias Braga, M.D., Daniela Bertolli Zanatta, Fabricio de Carvalho, Maria de Lourdes Chauffaille, Bryan E. Strauss, Gisele Wally Braga Colleoni, MD

Blood (2013) 122 (21): 3771.

https://doi.org/10.1182/blood.V122.21.3771.3771

Published: 2013

Journal Articles

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Fabricio de Carvalho, Veruska Lia, Fook Alves, Walter Moisés, Tobias Braga, M.D., Celso Vieira Xavier, Jr., Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4974.

https://doi.org/10.1182/blood.V120.21.4974.4974

Published: 2012

Journal Articles

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Walter Moises Tobias Braga, M.D., Bruna Raphaeli Silva, Fabricio de Carvalho, Veruska Lia Fook Alves, Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4985.

https://doi.org/10.1182/blood.V120.21.4985.4985

Published: 2012

NARROW

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Silencing of HSP70 and TRIAP1 Genes in Multiple Myeloma Cell Lines Induces Apoptosis through Apaf-1/Caspase 9 Pathway: New Potential Targets on the Way?

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Email alerts

ASH Publications

American Society of Hematology

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Silencing of HSP70 and TRIAP1 Genes in Multiple Myeloma Cell Lines Induces Apoptosis through Apaf-1/Caspase 9 Pathway: New Potential Targets on the Way?

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only